PBYI
PBYI
NASDAQ · Biotechnology

Puma Biotechnology Inc

$7.56
+0.33 (+4.56%)
As of Jun 21, 10:26 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -27.9% upside
Low Target $2.99
Average Target $5.45
High Target $6.80
Current Price $7.56
Current
$7.56
Target
$5.45
$2.99 $5.45 avg $6.80
Scenario Analysis
Bear Case
$2.99
-60.4%
Low target
Base Case
$5.45
-27.9%
Avg target
Bull Case
$6.80
+-10.1%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$7.90
-4.3% from high
52-Week Low
$3.03
+149.5% from low
Target vs 52W High
$5.45
-31.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -45.0%